Targets

Since this is your first visit to the site, you are seeing this message. It will not be displayed on subsequent visits.

Search Identity:
Query Sequence:

Enter list of identifiers or symbols:

Development Level

	Tbio	3 \| 10,625

Disease

	Chronic apical periodontitis	3 \| 3
	ovarian cancer	8,491 \| 8,491
	osteosarcoma	7,933 \| 7,933
	psoriasis	6,685 \| 6,685
	medulloblastoma, large-cell	6,234 \| 6,234
	glioblastoma	5,572 \| 5,572
	lung cancer	4,473 \| 4,473
	atypical teratoid / rhabdoid tumor	4,369 \| 4,369
	intraductal papillary-mucinous neoplasm (IPMN)	3,289 \| 3,289
	malignant mesothelioma	3,163 \| 3,163
	Breast cancer	3,098 \| 3,098
	pilocytic astrocytoma	3,086 \| 3,086
	primitive neuroectodermal tumor	3,031 \| 3,031
	intraductal papillary-mucinous carcinoma (IPMC)	2,988 \| 2,988
	intraductal papillary-mucinous adenoma (IPMA)	2,956 \| 2,956
	invasive ductal carcinoma	2,950 \| 2,950
	oligodendroglioma	2,849 \| 2,849
	lung carcinoma	2,844 \| 2,844
	non-small cell lung cancer	2,798 \| 2,798
	lung adenocarcinoma	2,714 \| 2,714
	pediatric high grade glioma	2,712 \| 2,712
	ependymoma	2,514 \| 2,514
	Cancer	2,346 \| 2,346
	pancreatic cancer	2,300 \| 2,300
	interstitial cystitis	2,299 \| 2,299
	subependymal giant cell astrocytoma	2,287 \| 2,287
	group 3 medulloblastoma	2,254 \| 2,254
	astrocytic glioma	2,241 \| 2,241
	adult high grade glioma	2,148 \| 2,148
	Carcinoma	2,147 \| 2,147
	ulcerative colitis	2,087 \| 2,087
	pituitary cancer	1,972 \| 1,972
	Pick disease	1,893 \| 1,893
	group 4 medulloblastoma	1,875 \| 1,875
	pancreatic ductal adenocarcinoma liver metastasis	1,795 \| 1,795
	ductal carcinoma in situ	1,745 \| 1,745
	cystic fibrosis	1,670 \| 1,670
	diabetes mellitus	1,663 \| 1,663
	breast carcinoma	1,614 \| 1,614
	tuberculosis	1,563 \| 1,563
	posterior fossa group B ependymoma	1,530 \| 1,530
	medulloblastoma	1,524 \| 1,524
	posterior fossa group A ependymoma	1,511 \| 1,511
	astrocytoma	1,493 \| 1,493
	sonic hedgehog group medulloblastoma	1,482 \| 1,482
	colon cancer	1,475 \| 1,475
	adrenocortical carcinoma	1,427 \| 1,427
	Multiple myeloma	1,327 \| 1,327
	primary pancreatic ductal adenocarcinoma	1,271 \| 1,271
	juvenile dermatomyositis	1,189 \| 1,189
	Rheumatoid Arthritis	1,170 \| 1,170
	acute quadriplegic myopathy	1,157 \| 1,157
	atypical teratoid/rhabdoid tumor	1,095 \| 1,095
	spina bifida	1,064 \| 1,064
	cutaneous lupus erythematosus	1,056 \| 1,056
	nasopharyngeal carcinoma	1,056 \| 1,056
	dermatomyositis	966 \| 966
	Atopic dermatitis	944 \| 944
	active Crohn's disease	918 \| 918
	non primary Sjogren syndrome sicca	840 \| 840
	gastric carcinoma	832 \| 832
	primary Sjogren syndrome	788 \| 788
	acute myeloid leukemia	785 \| 785
	Waldenstrons macroglobulinemia	764 \| 764
	esophageal adenocarcinoma	737 \| 737
	tuberculosis and treatment for 6 months	686 \| 686
	progressive supranuclear palsy	674 \| 674
	aldosterone-producing adenoma	664 \| 664
	Alzheimer's disease	644 \| 644
	Obesity	616 \| 616
	Duchenne muscular dystrophy	602 \| 602
	Intellectual disability	573 \| 573
	pancreatic carcinoma	567 \| 567
	fibroadenoma	557 \| 557
	hepatocellular carcinoma	550 \| 550
	Down syndrome	548 \| 548
	Endometriosis	535 \| 535
	chronic rhinosinusitis	512 \| 512
	Schizophrenia	503 \| 503
	autosomal dominant Emery-Dreifuss muscular dystrophy	499 \| 499
	Multiple Sclerosis	498 \| 498
	mucosa-associated lymphoid tissue lymphoma	480 \| 480
	active ulcerative colitis	477 \| 477
	Prostatic Neoplasms	471 \| 471
	IGA Glomerulonephritis	454 \| 454
	gastric cancer	436 \| 436
	Amyotrophic Lateral Sclerosis	432 \| 432
	non-small cell lung carcinoma	413 \| 413
	Mammary Neoplasms	410 \| 410
	inflammatory breast cancer	404 \| 404
	Kidney disease	397 \| 397
	Neurodegenerative disease	383 \| 383
	sarcoidosis	368 \| 368
	Parkinson's disease	364 \| 364
	Asthma	349 \| 349
	glioblastoma multiforme	347 \| 347
	Epilepsy	346 \| 346
	Polycystic Ovary Syndrome	334 \| 334
	nephrosclerosis	329 \| 329
	tuberculosis and treatment for 3 months	327 \| 327
	Autistic Disorder	320 \| 320

Target Family

	Transporter	2 \| 473
	Non-IDG	1 \| 11,969

This is where graphics are reside..

Name	Gene	Development Level	Target Family	Log Novelty	Pubmed Score	Antibody Count
Interleukin-34	IL34	Tbio	Non-IDG	-1.68892	56.0	202
Solute carrier family 52, riboflavin transporter, member 3	SLC52A3	Tbio	Transporter	-1.78983	64.2	19
Solute carrier family 52, riboflavin transporter, member 2	SLC52A2	Tbio	Transporter	-1.33741	19.7	25

Download

Aggregation Type

Overlay Data from

Knowledge Summary

Cluster Rank

Search for a Gene

Set column group size

	abnormal behavior	1 \| 226
	abnormal sensory capabilities-...	1 \| 3
	abnormal vibrissa morphology	1 \| 17
	absent vibrissae	1 \| 14
	decreased circulating creatini...	1 \| 31
	embryonic lethality prior to t...	1 \| 187
	enlarged lymph nodes	1 \| 27
	increased body weight	1 \| 42
	increased or absent threshold ...	1 \| 128
	preweaning lethality, complete...	1 \| 633
	small adrenal glands	1 \| 15

	Blood and immune system	3 \| 17,994
	Cardiovascular System	3 \| 17,957
	Digestive Tract	3 \| 18,472
	Endocrine System	3 \| 18,511
	Female tissues	3 \| 18,646
	Liver and Pancreas	3 \| 18,135
	Male tissues	3 \| 17,968
	Nervous System	3 \| 18,560
	Respiratory system	3 \| 17,483
	Skin and soft tissues	3 \| 18,114
	Urinary Tract	3 \| 18,443

Development Level

IMPC Phenotype

Disease

Tissue

Target Family

Target Development Level

Target Family

PANTHER Protein Ontology

GTEx Tissue

HPA RNA Tissue

HPM Tissue

JAX/MGI Phenotype

GO Component

UniProt Keywords

Grant Funding IC

Grant Activity

Data Source